Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MPM Bio IV NVS Strategic Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$24M
Portfolio companies 3
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Health Care
  • Women's
  • Pharmaceuticals
Summary

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the MPM Bio IV NVS Strategic Fund, startups are often financed by Wellcome Trust, Scottish Widows Investment Partnership, MPM Capital. The meaningful sponsors for the fund in investment in the same round are MPM Capital, BB Biotech Ventures, Wellcome Trust. In the next rounds fund is usually obtained by MPM Capital, BB Biotech Ventures, Wellcome Trust.

The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2014. This MPM Bio IV NVS Strategic Fund works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2009. The common things for fund are deals in the range of 10 - 50 millions dollars.

Among the various public portfolio startups of the fund, we may underline Proteon Therapeutics, Radius Health Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Health Care. The fund has no specific favorite in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of MPM Bio IV NVS Strategic Fund:
Typical Co-investors
MPM Bio IV NVS Strategic Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after MPM Bio IV NVS Strategic Fund:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3S Landing Pad California, San Francisco, United States
Aspire Systems Chennai, India, Tamil Nadu
Base Case Capital California, San Francisco, United States
Beiqing Ruichuang Beijing, Beijing Shi, China
Cedarville Investments Arkansas, Arkansas City, United States
Cooley California, Palo Alto, United States
Essel Group India, Maharashtra, Mumbai
Groupe Bertrand France, Ile-de-France, Paris
Itera Capital Distrito Federal, Mexico, Mexico City
K2 Investment Partners Seoul, Seoul-t'ukpyolsi, South Korea
Lauder Partners Atherton, California, United States
ProMutual Group Inc -
Salt Lake Life Science Angels Salt Lake City, United States, Utah
The Vinetta Project California, Los Angeles, United States
Tunisian American Enterprise Fund District of Columbia, United States, Washington
Whole Foods Market Austin, Texas, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Proteon Therapeutics

Biotechnology
Medical
Pharmaceutical
$50M28 May 2009 Massachusetts, United States

Radius Health

Biotechnology
Drug Discovery
Health Care
Health Diagnostics
Pharmaceutical
Pharmaceuticals
Women's
$15M20 Nov 2008 Cambridge, Massachusetts, United States

Radius Health

Biotechnology
Drug Discovery
Health Care
Health Diagnostics
Pharmaceutical
Pharmaceuticals
Women's
$10M17 Sep 2007 Cambridge, Massachusetts, United States

AVEO Oncology

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$5M05 May 2005 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MPM Bio IV NVS Strategic Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 24M
Peak activity year 2005
Lead investments 1
Follow on index 0.40
Exits 3
Group Appearance index 0.80

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Proteon Therapeutics

Biotechnology
Medical
Pharmaceutical
$50M28 May 2009 Massachusetts, United States

Radius Health

Biotechnology
Drug Discovery
Health Care
Health Diagnostics
Pharmaceutical
Pharmaceuticals
Women's
$15M20 Nov 2008 Cambridge, Massachusetts, United States

Radius Health

Biotechnology
Drug Discovery
Health Care
Health Diagnostics
Pharmaceutical
Pharmaceuticals
Women's
$10M17 Sep 2007 Cambridge, Massachusetts, United States

AVEO Oncology

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$5M05 May 2005 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: